ESOPHAGOGASTRIC JUCTION CANCER
Clinical trials for ESOPHAGOGASTRIC JUCTION CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGOGASTRIC JUCTION CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGOGASTRIC JUCTION CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive trial aims to find optimal Pre-Surgery combo for esophageal cancer
Disease control Recruiting nowThis large phase 3 study is testing different combinations of chemotherapy, radiation, immunotherapy, and targeted drugs given before surgery for esophageal cancer. The goal is to find which approach works best to improve survival. The trial will enroll 2,000 adults with stage I …
Matched conditions: ESOPHAGOGASTRIC JUCTION CANCER
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug JR8603 enters first human trial for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests the safety and effectiveness of a new drug called JR8603 in people with advanced solid tumors, including stomach and colorectal cancers, who have not responded to standard treatments. Participants receive JR8603 by IV infusion three times per month. T…
Matched conditions: ESOPHAGOGASTRIC JUCTION CANCER
Phase: PHASE1 • Sponsor: JiaRay Group • Aim: Disease control
Last updated Jun 26, 2026 15:14 UTC